-Healthcare Professionals
Collaborating With RLDC
Medical Literature
Healthcare Professionals > Collaborating With RLDC
Proposing New Research Studies, Partnering with the RLDC, and Utilizing Clinical Data and Biological Specimens
The RLDC was established to conduct the initial set of investigations that our investigators have outlined; and to provide an ongoing resource for collaboration with other investigators around the world. We welcome the potential to utilize the RLDC resources to advance biomedical science in areas ranging from basic laboratory to clinical therapeutics to clinical epidemiology, and other aspects of patient-oriented clinical investigation.
If you are an investigator interested in partnering with the RLDC, we ask that you initially contact the Director of the RLDC, Dr. Bruce Trapnell with a brief summary (one paragraph) of your proposal. If the proposal seems feasible, you will be asked to provide a more detailed protocol summary to the entire RLDC Steering Committee.
Copyright (c) 2022 Rare Lung Diseases | Privacy Statement | Terms Of Use
The RLDC (U54HL127672) was a part of the Rare Diseases Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research (ORDR), NCATS. This consortium was funded through a collaboration between the NCATS and the NHLBI.